News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
Shi-Yuan Cheng, PhD, professor in The Ken and Ruth Davee Department of Neurology in the Division of Neuro-oncology, has been named a fellow of the American Association for the Advancement of Science (AAAS) for his outstanding contributions to molecular and translational cancer research.
A new Northwestern Medicine study has identified tissue-specific epigenetic regulators in zebrafish, filling in a longtime gap in the understanding of the organism’s genome.
Research findings from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting, to be held virtually Dec. 5 – 8, 2020.* With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
Combining the current standard-of-care chemotherapy drug with a genetic inhibitor may improve treatment for pancreatic ductal adenocarcinoma, according to a recent study published in PNAS.
The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients. Anal cancer is a rare disease. The vast majority (90%) of new cases are the squamous cell type, associated with a human papillomavirus (HPV) infection.
A newly discovered function of an epigenetic regulator could be a key to new cancer treatments, according to a new study published in Genes and Development.
A new dataset — the result of a collaborative project between Khan and NUCATS Institute Chief AI Officer Yuan Luo, PhD — has made the process of reviewing thousands of patient histories increasingly possible.
Hi! My name is Mohammed Kadiri. I am 19 years old, and I am currently a sophomore at the University of Illinois at Urbana-Champaign. I am also serving as a member of Lurie Children’s Hospital AYA Advisory Council!
A brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma, according to a Northwestern Medicine trial.
Lurie Cancer Center’s Jyoti Patel, MD, an internationally recognized expert in the treatment of patients with lung cancer, discussed the latest information, advocacy and clinical trials for KRAS lung cancer, in a three-part webinar series hosted by Patient Power.
The Lurie Cancer Center is partnering with Chill, a Chicago-based meditation organization, to support our patients and staff by providing complimentary access to their app, Chill Anywhere.
A new three-dimensional imaging technique invented by Northwestern scientists greatly improves the visibility of brain tumors in magnetic resonance imaging scans.
The Lurie Cancer Center is pleased to announce the recipients of the 2020 IDP / Sherman Fairchild Foundation Research Innovation Challenge Awards.
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety and health of every patient, physician and staff member.
Treatment-resistant breast cancer could be made vulnerable to immunotherapy by flipping a metabolic “switch,” according to a new Northwestern Medicine study.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one's risk for developing aggressive prostate cancer.
By Anthony Morales
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
By Lauren Lopriore
See more news in the article archive.